These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1836179)

  • 41. High sensitivity for color mutants in lacZ plasmid-based transgenic mice, as detected by positive selection.
    Boerrigter ME
    Environ Mol Mutagen; 1998; 32(2):148-54. PubMed ID: 9776177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel lacI transgenic mutation-detection system and its application to establish baseline mutation frequencies in the scid mouse.
    Andrew SE; Pownall S; Fox J; Hsiao L; Hambleton J; Penney JE; Kohler SW; Jirik FR
    Mutat Res; 1996 Oct; 357(1-2):57-66. PubMed ID: 8876680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of spontaneous and chemical-induced lacI mutations in germ cells from lambda/lacI transgenic mice.
    Putman DL; Ritter AP; Carr GJ; Young RR
    Mutat Res; 1997 Feb; 388(2-3):137-43. PubMed ID: 9057874
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Towards validation of the Big Blue transgenic mouse mutagenesis assay: the mutational spectrum of ex vivo pinpoint mutant plaques.
    Nishino H; Buettner VL; Sommer SS
    Mutat Res; 1996 Nov; 372(1):97-105. PubMed ID: 9003536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methylation of CpG dinucleotides in the lacI gene of the Big Blue transgenic mouse.
    You YH; Halangoda A; Buettner V; Hill K; Sommer S; Pfeifer G
    Mutat Res; 1998 Dec; 420(1-3):55-65. PubMed ID: 9838042
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identifying DNA mutations in purified hematopoietic stem/progenitor cells.
    Cheng Z; Zhou T; Merchant A; Prihoda TJ; Wickes BL; Xu G; Walter CA; Rebel VI
    J Vis Exp; 2014 Feb; (84):e50752. PubMed ID: 24637843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target.
    Jakubczak JL; Merlino G; French JE; Muller WJ; Paul B; Adhya S; Garges S
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9073-8. PubMed ID: 8799156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LacI mutation spectra following benzo[a]pyrene treatment of Big Blue mice.
    Shane BS; de Boer J; Watson DE; Haseman JK; Glickman BW; Tindall KR
    Carcinogenesis; 2000 Apr; 21(4):715-25. PubMed ID: 10753208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of mutations in transgenic fish carrying a bacteriophage lambda cII transgene target.
    Winn RN; Norris MB; Brayer KJ; Torres C; Muller SL
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12655-60. PubMed ID: 11035814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of target gene CpG content on spontaneous mutation in299 transgenic mice.
    Skopek T; Marino D; Kort K; Miller J; Trumbauer M; Gopal S; Chen H
    Mutat Res; 1998 May; 400(1-2):77-88. PubMed ID: 9685590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of lambda phage shuttle vectors in transgenic mice for development of a short term mutagenicity assay.
    Short JM; Kohler SW; Provost GS; Feick A; Kretz PL
    Prog Clin Biol Res; 1990; 340A():355-67. PubMed ID: 1697073
    [No Abstract]   [Full Text] [Related]  

  • 52. Mutational spectra in the lacl gene in skin from 7,12-dimethylbenz[a]anthracene-treated and untreated transgenic mice.
    Gorelick NJ; Andrews JL; Gu M; Glickman BW
    Mol Carcinog; 1995 Sep; 14(1):53-62. PubMed ID: 7546225
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of mutations by 2-acetylaminofluorene in lacI transgenic B6C3F1 mouse liver.
    Ross JA; Leavitt SA
    Mutagenesis; 1998 Mar; 13(2):173-9. PubMed ID: 9568591
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms.
    Recio L; Steen AM; Pluta LJ; Meyer KG; Saranko CJ
    Chem Biol Interact; 2001 Jun; 135-136():325-41. PubMed ID: 11397399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validation studies with Muta Mouse: a transgenic mouse model for detecting mutations in vivo.
    Myhr BC
    Environ Mol Mutagen; 1991; 18(4):308-15. PubMed ID: 1836178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transgenic lambda/lacI mutagenicity assay: statistical determination of sample size.
    Callahan JD; Short JM
    Mutat Res; 1995 Mar; 327(1-2):201-8. PubMed ID: 7870088
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutation frequency in the lacI gene of liver DNA from lambda/lacI transgenic mice following the interaction of PCBs with iron causing hepatic cancer and porphyria.
    Davies R; Clothier B; Smith AG
    Mutagenesis; 2000 Sep; 15(5):379-83. PubMed ID: 10970442
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular characterization of mitomycin C-induced large deletions and tandem-base substitutions in the bone marrow of gpt delta transgenic mice.
    Takeiri A; Mishima M; Tanaka K; Shioda A; Ueda O; Suzuki H; Inoue M; Masumura K; Nohmi T
    Chem Res Toxicol; 2003 Feb; 16(2):171-9. PubMed ID: 12588188
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transgenic zebrafish for detecting mutations caused by compounds in aquatic environments.
    Amanuma K; Takeda H; Amanuma H; Aoki Y
    Nat Biotechnol; 2000 Jan; 18(1):62-5. PubMed ID: 10625393
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutagenicity of 2-[2-(acetylamino)-4-[bis(2-hydroxyethyl)amino]-5-methoxyphenyl]-5-amino-7-bromo-4-chloro-2H-benzotriazole (PBTA-6) and benzo[a]pyrene (BaP) in the gill and hepatopancreas of rpsL transgenic zebrafish.
    Amanuma K; Tone S; Nagaya M; Matsumoto M; Watanabe T; Totsuka Y; Wakabayashi K; Aoki Y
    Mutat Res; 2008 Oct; 656(1-2):36-43. PubMed ID: 18675378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.